In turn, once uPAR is conjugated to the nanoparticles, the resulting conjugates exhibit markedly longer residence times compared with uPAR-targeted peptides; (iii) passive distribution via leaky tumor vasculature is also thought to facilitate cancer-specific retention. This evidence concerns the gene PLAUR and cancer.